The one of a kind database called ‘Ab-CoV’ contains detailed information about all COVID-related antibodies identified so far, including the source of each.
Team from Maulana Azad Medical College collected blood samples from 27,811 participants in Delhi between 24 September & 14 October 2021. Report on findings shared with govt earlier.
REGEN-COV received emergency use authorisation from US FDA. It is meant to treat mild-to-moderate Covid patients who aren't on oxygen support but who may be at risk of severe disease.
Vaccines often require boosters, but they aren’t our only option & in some cases may not even be our best. Fortunately, there’s another promising option: monoclonal antibody treatment.
According to Neelkanth Mishra, a top official at Credit Suisse, many districts could have herd immunity. However he noted this was just a hypothesis and an actual sero survey should follow.
A US study looked at bone marrow of recovered Covid patients and found plasma cells that can specifically recognise the spike protein of the coronavirus, upto 11 months after infection.
Several studies have compared the difference between antibodies produced after Covid and those that can be detected six months later. The findings are impressive.
Monoclonal antibodies are man-made proteins made to mimic the body’s immune response to a pathogen. The mutant strains are found to throw off these antibodies.
The current Iran war has laid bare a fundamental reality: 20 per cent of global energy trade cannot afford to rely on a single artery, no matter how resilient and cost-effective.
Regulator seeks feedback on allowing firms to repurchase shares via exchanges after tax changes, as markets reel from war-led selloff and foreign outflows.
China patiently invested capital, skill and technology in coal gasification. Unlike it, we won’t move from words to action. As crude prices decline, we lose interest.
COMMENTS